These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 3316874

  • 1. Effects of calcium antagonism on the resting and exercise-stimulated renin-aldosterone axis.
    Hespel P, Lijnen P, Fiocchi R, Lissens W, Moerman E, Amery A.
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):461-7. PubMed ID: 3316874
    [Abstract] [Full Text] [Related]

  • 2. Effects of felodipine on blood pressure and humoral factors in sodium-replete humans at rest and during exercise.
    Lijnen P, Hespel P, Fagard R, Staessen J, M'Buyamba-Kabangu JR, Moerman E, Amery A.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 10():S122-5. PubMed ID: 2455111
    [Abstract] [Full Text] [Related]

  • 3. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G, Cottone S, Mangano MT, D'Ignoto G, Pinto A, Carone MB.
    Clin Ther; 1988 Jul; 10(6):694-703. PubMed ID: 2975530
    [Abstract] [Full Text] [Related]

  • 4. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension.
    Katzman PL, Hulthén UL, Hökfelt B.
    Acta Med Scand; 1988 Jul; 223(2):125-31. PubMed ID: 3279724
    [Abstract] [Full Text] [Related]

  • 5. Catecholamines, renin-angiotensin-aldosterone, and cardiovascular response during exercise following acute and long-term calcium antagonism with felodipine in essential hypertension.
    Katzman PL, Hulthén UL, Hökfelt B.
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):439-44. PubMed ID: 2444797
    [Abstract] [Full Text] [Related]

  • 6. The natriuretic effect of the dihydropyridine calcium antagonist felodipine: a placebo-controlled study involving intravenous angiotensin II in normotensive volunteers.
    Sluiter HE, Wetzels JF, Huysmans FT, Koene RA.
    J Cardiovasc Pharmacol; 1987 Oct; 10 Suppl 10():S154-61. PubMed ID: 2455121
    [Abstract] [Full Text] [Related]

  • 7. Calcium antagonism with felodipine in essential hypertension. Effects on cardiovascular and renal function, the sympathetic and the renin-angiotensin-aldosterone systems, glucose tolerance and glucoregulatory hormones.
    Katzman PL.
    Acta Med Scand Suppl; 1987 Oct; 720():1-62. PubMed ID: 3328471
    [No Abstract] [Full Text] [Related]

  • 8. The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension.
    Katzman PL, Hulthén UL, Hökfelt B.
    Br J Clin Pharmacol; 1986 Jun; 21(6):633-40. PubMed ID: 3527242
    [Abstract] [Full Text] [Related]

  • 9. Effects of felodipine and metoprolol on blood pressure, plasma renin, angiotensin II, aldosterone and catecholamines in hypertensive patients.
    Lijnen P, Fagard R, Staessen J, Moerman E, De Schaepdryver A, Amery A.
    Drugs; 1987 Jun; 34 Suppl 3():170-5. PubMed ID: 3327678
    [Abstract] [Full Text] [Related]

  • 10. Effect of calcium antagonism on intracellular concentrations and transmembrane fluxes of cations in erythrocytes of men at rest and during exercise.
    Hespel P, Lijnen P, Fiocchi R, Lissens W, Amery A.
    J Hypertens; 1986 Dec; 4(6):767-72. PubMed ID: 3819391
    [Abstract] [Full Text] [Related]

  • 11. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
    Kruse HJ, Kreutz R, Staib S, Overlack A, Stumpe KO, Kolloch RE.
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
    [Abstract] [Full Text] [Related]

  • 12. Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.
    Leonetti G, Gradnik R, Terzoli L, Fruscio M, Rupoli L, Zanchetti A.
    J Cardiovasc Pharmacol; 1984 Oct; 6(3):392-8. PubMed ID: 6202963
    [Abstract] [Full Text] [Related]

  • 13. Catecholamines and the renin-angiotensin-aldosterone system during treatment with felodipine ER or hydrochlorothiazide in essential hypertension.
    Koenig W, Binner L, Gabrielsen F, Sund M, Rosenthal J, Hombach V.
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):349-53. PubMed ID: 1720834
    [Abstract] [Full Text] [Related]

  • 14. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J, Tree M, Brown JJ, Fraser R, Lever AF, Millar JA, Morton JJ, Robertson JI, Reid JL, Hamilton C.
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [Abstract] [Full Text] [Related]

  • 15. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH, Reams GP, Wu Z, Lau-Sieckman A.
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [Abstract] [Full Text] [Related]

  • 16. Effect of the dopamine agonist bromocriptine on blood pressure, catecholamines and renin activity in acromegalics at rest, following exercise and during insulin induced hypoglycemia.
    Nilsson A, Hökfelt B.
    Acta Endocrinol Suppl (Copenh); 1978 Apr; 216():83-96. PubMed ID: 274039
    [Abstract] [Full Text] [Related]

  • 17. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
    Ignatowska-Switalska H, Wocial B, Skórka B, Chodakowska J, Nazar K, Chwalbińska-Moneta J.
    Acta Physiol Pol; 1980 Apr; 31(6):631-5. PubMed ID: 7018172
    [Abstract] [Full Text] [Related]

  • 18. Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients.
    Leonetti G, Gradnik R, Terzoli L, Fruscio M, Rupoli L, Cuspidi C, Sampieri L, Zanchetti A.
    J Cardiovasc Pharmacol; 1986 Apr; 8(6):1243-8. PubMed ID: 2434753
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.